Provider
QP61-18 Availity Authorization Training with Live Demo
Program effective Date: Aug 06, 2018
Search Results
Displaying 3011 - 3020 of 3655 results
Provider
QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir)
Program effective Date: Aug 21, 2018
Provider
QP72-18 Pharmacy Benefit Update - New Drug-Related Step Therapy with Quantity Limit Criteria: Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors
Program effective Date: Aug 21, 2018
Provider
QP28-17 Notification of Provider Submitted Appeals
Program effective Date: Sep 12, 2017
Provider
QP60R1-18 Update: Change to Call Center for Transportation for MHCP Members
Program effective Date: Sep 14, 2018
Provider
QP62-18 2018 Fall Blue Cross Basic Seminars to Include Availity Portal Training
Program effective Date: Aug 14, 2018
Provider
QP39-16 Digital Breast Tomosynthesis (DBT) for Routine Breast Cancer Screening
Program effective Date: Dec 15, 2016
Provider
QP56-18 Availity Authorization Portal Update
Program effective Date: Jul 18, 2018
Provider
QP28-16 Reminders for Providers who Provide Interpreter Services for MHCP Subscribers
Program effective Date: Oct 14, 2016
Provider
QP19-16 Incomplete Information on Post Service Appeals
Program effective Date: Jul 26, 2016